Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction

White, 1987, Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction, N Engl J Med, 317, 850, 10.1056/NEJM198710013171402 Grines, 1993, A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction, N Engl J Med, 328, 673, 10.1056/NEJM199303113281001 1993, The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction, N Engl J Med, 329, 1615, 10.1056/NEJM199311253292204 Morishima, 1995, Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty, Am Heart J, 130, 239, 10.1016/0002-8703(95)90434-4 Ito, 1992, Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction, Circulation, 85, 1699, 10.1161/01.CIR.85.5.1699 Ames, 1968, The no-reflow phenomenon, Am J Pathol, 52, 437 Kloner, 1974, The “no-reflow” phenomenon after temporary coronary occlusion in the dog, J Clin Invest, 54, 1496, 10.1172/JCI107898 Ragosta, 1994, Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography, Circulation, 89, 2562, 10.1161/01.CIR.89.6.2562 Schofer, 1985, Scintigraphic evidence of the “no reflow” phenomenon in human beings after coronary thrombolysis, J Am Coll Cardiol, 5, 593, 10.1016/S0735-1097(85)80381-8 Kondo, 1998, Assessment of “microvascular no-reflow phenomenon” using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction, J Am Coll Cardiol, 32, 898, 10.1016/S0735-1097(98)00435-5 Ishihara, 1996, Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine, Am Heart J, 132, 959, 10.1016/S0002-8703(96)90005-8 Piana, 1994, Incidence and treatment of ‘no-reflow’ after percutaneous coronary intervention, Circulation, 89, 2514, 10.1161/01.CIR.89.6.2514 Taniyama, 1997, Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction, J Am Coll Cardiol, 30, 1193, 10.1016/S0735-1097(97)00277-5 Iwakura, 1996, Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction, Circulation, 94, 1269, 10.1161/01.CIR.94.6.1269 Tsunoda, 1998, The pattern of alteration in flow velocity in the recanalized artery is related to left ventricular recovery in patients with acute infarction and successful direct balloon angioplasty, J Am Coll Cardiol, 32, 338, 10.1016/S0735-1097(98)00228-9 Ito, 1996, Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction, Circulation, 93, 1993, 10.1161/01.CIR.93.11.1993 van’t Hof, 1998, Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Myocardial blush grade, Circulation, 97, 2302, 10.1161/01.CIR.97.23.2302 Pfeffer, 1990, Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications, Circulation, 81, 1161, 10.1161/01.CIR.81.4.1161 Gaudron, 1993, Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors, Circulation, 87, 755, 10.1161/01.CIR.87.3.755 St. John Sutton, 1997, Cardiovascular death and left ventricular remodeling two years after myocardial infarction. Baseline predictors and impact of long-term use of captopril, Circulation, 96, 3294, 10.1161/01.CIR.96.10.3294 Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Tsuji, 1994, Stabilization of human brain natriuretic peptide in blood samples, Clin Chem, 40, 672, 10.1093/clinchem/40.4.672 Engler, 1983, Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog, Am J Pathol, 111, 98 Meisel, 1998, Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction. Possible implications for leukocyte aggregation and microvascular plugging, J Am Coll Cardiol, 31, 120, 10.1016/S0735-1097(97)00424-5 Ito, 1996, Clinical implications of the ‘no reflow’ phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction, Circulation, 93, 223, 10.1161/01.CIR.93.2.223 McKay, 1986, Left ventricular remodeling after myocardial infarction, Circulation, 74, 693, 10.1161/01.CIR.74.4.693 Bolognese, 1997, Influence of infarct-zone viability on left ventricular remodeling after acute myocardial infarction, Circulation, 96, 3353, 10.1161/01.CIR.96.10.3353 Whittaker, 1997, Collagen and ventricular remodeling after acute myocardial infarction, Basic Res Cardiol, 92, 79, 10.1007/BF00805566 Dollery, 1995, Matrix metalloproteinases and cardiovascular disease, Circ Res, 77, 863, 10.1161/01.RES.77.5.863 Carlyle, 1997, Delayed reperfusion alters matrix metalloproteinase activity and fibronectin mRNA expression in the infarct zone of the ligated rat heart, J Moll Cell Cardiol, 29, 2451, 10.1006/jmcc.1997.0482 Mukoyama, 1991, Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide, J Clin Invest, 87, 1402, 10.1172/JCI115146 Motwani, 1993, Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction, Lancet, 341, 1109, 10.1016/0140-6736(93)93126-L Omland, 1996, Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide, Circulation, 93, 1963, 10.1161/01.CIR.93.11.1963 Darbar, 1996, Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction, Am J Cardiol, 78, 284, 10.1016/S0002-9149(96)00278-0 Tsutamoto, 1997, Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction, Circulation, 96, 509, 10.1161/01.CIR.96.2.509 Sumida, 1995, Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction, J Am Coll Cardiol, 25, 1105, 10.1016/0735-1097(94)00525-U Ross, 1998, Extended mortality benefit of early postinfarction reperfusion, Circulation, 97, 1549, 10.1161/01.CIR.97.16.1549